Regeneron Pharmaceuticals Officer Marion McCourt Files Form 144 to Sell $1.03M in Common Stock
REGENERON PHARMACEUTICALS, INC.
Subscribe to track REGN
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 144 Notice of Proposed Sale Issuer: REGENERON PHARMACEUTICALS, INC. ($REGN) Insider: Marion McCourt (Officer) Proposed Sale Amount: 1,215 shares (~$1,032,750.00) Approx. Date of Sale: 09/02/2026 Broker: UBS Financial Services Inc. Plan Adoption Date: 02/17/2026 (Rule 10b5-1)
Comprehensive Analysis
Transaction Overview
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Officer Marion McCourt filed a Form 144 on September 2, 2026, indicating a proposed sale of 1,215 shares of Common Stock with an estimated aggregate market value of $1,032,750.00 ($850.00 per share).
Origin of Securities
The shares slated for sale were acquired via restricted stock award (RSA) vestings:
- 224 shares acquired on 02/12/2023
- 263 shares acquired on 12/09/2024
- 728 shares acquired on 12/16/2024
Trading Plan & Market Context
- Rule 10b5-1 Plan: The transaction is scheduled pursuant to a pre-arranged trading plan adopted on February 17, 2026.
- Significance: Low. The 1,215 shares represent a negligible fraction of the company's 101,137,842 outstanding shares and execution occurs under a planned Rule 10b5-1 schedule.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.